Immune-mediated inflammatory disease
3 papers4 findings
- Humans3
Effects
3Myocardial infarction
upin humans1
1 study
Myocardial infarction
upin humans1
Immune-mediated inflammatory disease increases myocardial infarction in humans (12.9 vs. 8.6 per 1000 person-years).
“greater incidence of MI/revascularization (12.9 vs. 8.6 per 1000 person-years) than matched controls (n = 2190)”
Humanscompared to matched controlsn = 1,095
AHA Scientific Sessions 2025 abstract3 Nov 2025
Epicardial adipose tissue volume
upin humans1
1 study
Epicardial adipose tissue volume
upin humans1
Immune-mediated inflammatory disease increases epicardial adipose tissue volume in humans (p<0.005).
“IMID patients (N=1095, SLE: 162, RA: 557, Psoriasis: 430) had significantly higher EAT volume (p<0.005)”
Humanscompared to matched controlsn = 1,095
AHA Scientific Sessions 2025 abstract3 Nov 2025
Senescent CD8+ T cells
upin humans1
1 study
Senescent CD8+ T cells
upin humans1
Immune-mediated inflammatory disease increases senescent CD8+ T cells in humans.
“T8sen, but not T4sen, accumulated more in patients with IMIDs than in patients with lung cancer and healthy donors.”
Humansin IMID patients compared to lung cancer patients and healthy donors
Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokines
Clinical and experimental immunology21 Jan 2025
Associations
1Incident myocardial infarction or coronary revascularization
upin humans1
1 study
Incident myocardial infarction or coronary revascularization
upin humans1
Immune-mediated inflammatory disease raises the risk of incident myocardial infarction or coronary revascularization in humans (six-fold higher (7.13 vs 1.12 per 1000 person-years)).
“Among patients with no coronary calcium, IMID patients experienced a six-fold higher event rate than controls (7.13 vs 1.12 per 1000 person-years).”
Humansin patients with zero CAC
AHA Scientific Sessions 2025 abstract3 Nov 2025
More on Incident myocardial infarction or coronary revascularization
Trial sponsors
Company1 trialPhase 151 people